Lv1
60 积分 2022-03-17 加入
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
3个月前
已完结
741 First in humaun phase I trial of DT-9081, a selective EP4 receptor antagonist in patients with recurrent and or metastatic solids tumors
3个月前
已完结
Abstract 2208: Combination of the EP4 antagonist CR6086 and anti-PD-1 monoclonal antibody inhibits tumor growth in a microsatellite stable colorectal cancer in mice
3个月前
已关闭
TRPA1 Antagonist LY3526318 Inhibits the Cinnamaldehyde‐Evoked Dermal Blood Flow Increase: Translational Proof of Pharmacology
10个月前
已完结
Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals
11个月前
已完结
Development of a First-Generation Stereocontrolled Manufacturing Process of TRPA1 Inhibitor GDC-6599
11个月前
已完结
Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels
1年前
已完结
Kv1.3 in the spotlight for treating immune diseases
1年前
已完结
皖公网安备34019202002308
